Genetown
Filter News
Found 57,155 articles
-
Help us identify the leading employers in the life science industry! We want to uncover who leads in key areas like diversity, culture, unique benefits and, of course, who are the 2019 Life Sciences Ideal Employers.
-
Comet has set up shop in Kendall Square with about 10 employees. The company has plans to expand to at least double that amount over the next year as it moves from the preclinical phase to the clinical phase.
-
When Becky Fu met Brett Robb at a CRISPR conference four years ago, they were both deeply involved in CRISPR. The two published a paper in March in Nature Microbiology on the subject and on Fu’s findings on the complex mechanisms of the Cpf1 nucleases, a different set of enzymes than the often-us...
-
The drug showed a statistically significant and clinically meaningful improvement in overall abdominal symptoms compared to placebo for all primary and secondary endpoints.
-
Locust Walk Further Expands Financing Team with Appointments of Neil Higgins and Turner Grant
6/19/2019
Locust Walk, a global life science transaction firm, today announced the appointments of Neil Higgins, Managing Director of Financing, and Turner Grant, Senior Vice President of Financing
-
Eric J. Rubin, MD, PhD, Named Editor-in-Chief of the New England Journal of Medicine and NEJM Group
6/19/2019
The Massachusetts Medical Society, publisher of the New England Journal of Medicine, today named Eric J. Rubin, MD, PhD, the new editor-in-chief of the Journal and NEJM Group.
-
Kymera Therapeutics to Present New Preclinical Data for its First-In-Class Oral IRAK4 Degrader in MYD88-Mutant B Cell Lymphoma at the 15th International Conference on Malignant Lymphoma
6/19/2019
KYM-001 causes potent and selective IRAK4 protein knockdown and regression of OCI-LY10 tumor xenografts, both alone and in combination with BTK inhibition
-
Entrada Therapeutics Appoints John F. Crowley to Board of Directors
6/19/2019
Entrada Therapeutics is a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologic
-
Sesen Bio Announces Pricing of Public Offering of Common Stock and Warrants
6/19/2019
The gross proceeds of the offering to the Company are expected to be approximately $30 million.
-
Global Coalition for Adaptive Research's Innovative Clinical Trial Platform Opens to Evaluate New Therapies for Brain Cancer
6/19/2019
The Global Coalition for Adaptive Research (GCAR) announced today that the GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) clinical trial is opening its first clinical site, the Henry Ford Cancer Institute, and will begin enrolling patients this week.
-
MicroMedicine to Present at the 34th Annual 2019 CYTO Congress of the International Society for Advancement of Cytometry
6/19/2019
MicroMedicine, Inc., a life sciences technology company, today announced that it will be hosting its first Commercial Tutorial at the 34th annual 2019 CYTO Congress of the International Society for Advancement of Cytometry (ISAC) in Vancouver, BC, Canada
-
Seres Therapeutics Issues Statement Regarding U.S. Food and Drug Administration Safety Alert Related to Use of Fecal Microbiota Transplantation
6/19/2019
FDA alert does not impact Seres’ microbiome investigational therapeutic candidates
-
Comet Therapeutics Raises $28.5 Million Series A Financing to Support Development of Treatments Built Around Its Novel CoEnzyme A Platform
6/19/2019
Funding led by Canaan and Sofinnova Partners To Advance Unique Approach to Immuno-metabolism And Neuro-metabolism.
-
Harbour BioMed Appoints Immunology Research Leader Kenneth M. Murphy, MD, PhD, to Its Scientific Advisory Board
6/19/2019
Harbour BioMed announced the appointment of Kenneth M. Murphy, MD, PhD, to the company’s scientific advisory board. Dr. Murphy, a member of the National Academy of Sciences and a Howard Hughes Medical Institute Investigator, is the Eugene Opie First Centennial Professor of Pathology and Immunology at Washington University.
-
Harvard Launches New MS/MBA Biotechnology: Life Sciences Joint Degree
6/19/2019
Harvard Business School (HBS) and Harvard's Graduate School of Arts and Sciences (GSAS) announced today a new joint master's degree program that aims to prepare future leaders at the interface of life sciences and business
-
Shimmer and ClearSky Announce Partnership to Improve Analysis of Wearable Sensor Data for CNS Diseases
6/19/2019
Shimmer Research, a global leader in wearable technology for research applications, and ClearSky Medical Diagnostics, a leader in analyzing wearable data for medical applications, today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical research
-
CENTOGENE Accelerates Rare Disease Diagnosis with new Artificial Intelligence Solution
6/18/2019
Variant Prioritization Tool Driven by World’s Largest Curated Mutation Database
-
BeiGene and SpringWorks Therapeutics Announce the Formation of MapKure to Develop BGB-3245, an Investigational, Selective Next-Generation RAF Kinase Inhibitor
6/18/2019
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced the formation of MapKure, LLC,
-
Study Presented at American Diabetes Association 79th Scientific Sessions Observed Substantially Less Hypoglycemia With Use of Glytec’s Technology
6/18/2019
Delivering the highest quality care in accordance with best practice is a fundamental tenet of diabetes and glycemic management at Grady Hospital of Atlanta, Georgia, which is why in 2016, the academic medical center chose to standardize its approach and elevate both safety and efficacy by implementing Glytec’s eGlycemic Management System® (eGMS®) in its intensive care and step-down units
-
Helen Moore, PhD, Joins Applied BioMath, LLC, as Director of Applied Mathematics
6/18/2019
Applied BioMath (www.appliedbiomath.com), the industry leader in applying mechanistic modeling, simulation, and analysis to accelerate and de-risk drug research and development, is proud to welcome Helen Moore, PhD, as Director of Applied Mathematics.